These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 19860661)

  • 1. B-type natriuretic peptide: endogenous regulator of myocardial structure, biomarker and therapeutic target.
    Ritchie RH; Rosenkranz AC; Kaye DM
    Curr Mol Med; 2009 Sep; 9(7):814-25. PubMed ID: 19860661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of brain natriuretic peptide as marker of left ventricular dysfunction and hypertrophy in the population.
    Luchner A; Burnett JC; Jougasaki M; Hense HW; Heid IM; Muders F; Riegger GA; Schunkert H
    J Hypertens; 2000 Aug; 18(8):1121-8. PubMed ID: 10954005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of TRPC6 channel activity contributes to the antihypertrophic effects of natriuretic peptides-guanylyl cyclase-A signaling in the heart.
    Kinoshita H; Kuwahara K; Nishida M; Jian Z; Rong X; Kiyonaka S; Kuwabara Y; Kurose H; Inoue R; Mori Y; Li Y; Nakagawa Y; Usami S; Fujiwara M; Yamada Y; Minami T; Ueshima K; Nakao K
    Circ Res; 2010 Jun; 106(12):1849-60. PubMed ID: 20448219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ventricular production of natriuretic peptides and ventricular structural remodeling in hypertensive heart failure.
    Sakata Y; Yamamoto K; Masuyama T; Mano T; Nishikawa N; Kuzuya T; Miwa T; Hori M
    J Hypertens; 2001 Oct; 19(10):1905-12. PubMed ID: 11593113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of endocardial natriuretic peptide receptors in right ventricular hypertrophy.
    Kim SZ; Cho KW; Kim SH
    Am J Physiol; 1999 Dec; 277(6):H2280-9. PubMed ID: 10600847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of natriuretic peptide receptor guanylyl cyclase-A in myocardial infarction evaluated using genetically engineered mice.
    Nakanishi M; Saito Y; Kishimoto I; Harada M; Kuwahara K; Takahashi N; Kawakami R; Nakagawa Y; Tanimoto K; Yasuno S; Usami S; Li Y; Adachi Y; Fukamizu A; Garbers DL; Nakao K
    Hypertension; 2005 Aug; 46(2):441-7. PubMed ID: 15998711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential expression of cardiac ANP and BNP in a rabbit model of progressive left ventricular dysfunction.
    Luchner A; Muders F; Dietl O; Friedrich E; Blumberg F; Protter AA; Riegger GA; Elsner D
    Cardiovasc Res; 2001 Aug; 51(3):601-7. PubMed ID: 11476751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolonged effects of B-type natriuretic peptide infusion on cardiac remodeling after sustained myocardial injury.
    George I; Morrow B; Xu K; Yi GH; Holmes J; Wu EX; Li Z; Protter AA; Oz MC; Wang J
    Am J Physiol Heart Circ Physiol; 2009 Aug; 297(2):H708-17. PubMed ID: 19525373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Left ventricular assist device support reverses altered cardiac expression and function of natriuretic peptides and receptors in end-stage heart failure.
    Kuhn M; Voss M; Mitko D; Stypmann J; Schmid C; Kawaguchi N; Grabellus F; Baba HA
    Cardiovasc Res; 2004 Nov; 64(2):308-14. PubMed ID: 15485690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GYY4137 attenuates remodeling, preserves cardiac function and modulates the natriuretic peptide response to ischemia.
    Lilyanna S; Peh MT; Liew OW; Wang P; Moore PK; Richards AM; Martinez EC
    J Mol Cell Cardiol; 2015 Oct; 87():27-37. PubMed ID: 26254181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relevance of brain natriuretic peptide in preload-dependent regulation of cardiac sarcoplasmic reticulum Ca2+ ATPase expression.
    Kögler H; Schott P; Toischer K; Milting H; Van PN; Kohlhaas M; Grebe C; Kassner A; Domeier E; Teucher N; Seidler T; Knöll R; Maier LS; El-Banayosy A; Körfer R; Hasenfuss G
    Circulation; 2006 Jun; 113(23):2724-32. PubMed ID: 16754798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of myocardial fibrosis, B-type natriuretic peptide, and cardiac magnetic resonance parameters of remodeling in chronic ischemic cardiomyopathy.
    Henkel DM; Glockner J; Miller WL
    Am J Cardiol; 2012 Feb; 109(3):390-4. PubMed ID: 22078219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B-Type Natriuretic Peptide Deletion Leads to Progressive Hypertension, Associated Organ Damage, and Reduced Survival: Novel Model for Human Hypertension.
    Holditch SJ; Schreiber CA; Nini R; Tonne JM; Peng KW; Geurts A; Jacob HJ; Burnett JC; Cataliotti A; Ikeda Y
    Hypertension; 2015 Jul; 66(1):199-210. PubMed ID: 26063669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atorvastatin prevents connexin43 remodeling in hypertrophied left ventricular myocardium of spontaneously hypertensive rats.
    Chen HJ; Yao L; Chen TG; Yu M; Wang LH; Chen JZ
    Chin Med J (Engl); 2007 Nov; 120(21):1902-7. PubMed ID: 18067764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antihypertrophic actions of the natriuretic peptides in adult rat cardiomyocytes: importance of cyclic GMP.
    Rosenkranz AC; Woods RL; Dusting GJ; Ritchie RH
    Cardiovasc Res; 2003 Feb; 57(2):515-22. PubMed ID: 12566124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Roles of guanylyl cyclase--a signaling in the cardiovascular system.
    Saito Y; Kishimoto I; Nakao K
    Can J Physiol Pharmacol; 2011 Aug; 89(8):551-6. PubMed ID: 21671770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of plasma levels of N-terminal Pro-B-type natriuretic peptide on left ventricular remodeling in non-obstructive hypertrophic cardiomyopathy attributable to the Asp175Asn mutation in the alpha-tropomyosin gene.
    Magga J; Sipola P; Vuolteenaho O; Risteli J; Jääskeläinen P; Peuhkurinen K; Kuusisto J
    Am J Cardiol; 2008 Apr; 101(8):1185-90. PubMed ID: 18394456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential expression of natriuretic peptides and their receptors in volume overload cardiac hypertrophy in the rat.
    Su X; Brower G; Janicki JS; Chen YF; Oparil S; Dell'Italia LJ
    J Mol Cell Cardiol; 1999 Oct; 31(10):1927-36. PubMed ID: 10525429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natriuretic peptides: an update on bioactivity, potential therapeutic use, and implication in cardiovascular diseases.
    Rubattu S; Sciarretta S; Valenti V; Stanzione R; Volpe M
    Am J Hypertens; 2008 Jul; 21(7):733-41. PubMed ID: 18464748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atrial natriuretic peptide helps prevent late remodeling after left ventricular aneurysm repair.
    Tsuneyoshi H; Nishina T; Nomoto T; Kanemitsu H; Kawakami R; Unimonh O; Nishimura K; Komeda M
    Circulation; 2004 Sep; 110(11 Suppl 1):II174-9. PubMed ID: 15364859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.